Tong Ren Tang Technologies Aktie - TNG

Rendering Error

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,61

Gebot

0,58

Fragen

0,64

Volumen

0,00

0,00 Tagesbereich 0,00

0,545 52-Wochen-Bereich 0,795

Handelsende

0,61

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

8.322

Finanzvolumen

VWAP

INSERTING AND REPLACING: Transgene Reports 2013 Half Year Results

€72 million (above $90 million) in cash at end of June 2013 Important news-flow in Q4 for the two lead programs, TG4010 and Pexa-Vec...

Transgene Reports 2013 Half Year Results

€72 million (above $90 million) in cash at end of June 2013 Important news-flow in Q4 for the two lead programs, TG4010 and Pexa-Vec...

Transgene Announces that its Phase 2 study of Pexa-Vec in Second-line Advanced Liver Cancer did not Meet its Primary Endpoint

Conducting additional analyses of data, continuing to advance clinical trials in other cancers Announcing decision on Phase 3...

Transgene Grants Ascend Biopharmaceuticals a License to TG1042, an Immunotherapy to Treat Basal Cell Carcinoma, a Common Type...

Regulatory News: Transgene SA (Paris:TNG) (Euronext Paris: TNG), a biopharmaceutical company that develops targeted immunotherapy...

Transgene Announces the Nomination of Two New Board Members

Prof. Laurence Zitvogel (MD) and Mr Jean-Luc Bélingard were elected to the board at the AGM held on June 19, 2013

Transgene Announces that Platine Pharma Services, an Affiliate, is to Acquire Immuno-Monitoring Activities of Indicia Biotech...

Transaction will grow Platine Pharma Services’ business by 50% Transgene’s shareholding in Platine will be reduced to around 30%

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0.065	11.9266055046	0.545	0.59	0.545	19300	0.58580311	DE
12	-0.03	-4.6875	0.64	0.645	0.545	8322	0.58804134	DE
26	-0.08	-11.5942028986	0.69	0.795	0.545	10175	0.62113235	DE
52	-0.1	-14.0845070423	0.71	0.795	0.545	8863	0.62116191	DE
156	-0.155	-20.2614379085	0.765	0.8	0.545	5695	0.6372782	DE
260	-0.155	-20.2614379085	0.765	0.8	0.545	5695	0.6372782	DE

TNG - Frequently Asked Questions (FAQ)

What is the current Tong Ren Tang Technologies share price?

The current share price of Tong Ren Tang Technologies is 0,61 €

What is the 1 year trading range for Tong Ren Tang Technologies share price?

Tong Ren Tang Technologies has traded in the range of 0,545 € to 0,795 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AMIMedondo Holding AG	0,498 € (91,54%)	100
6XCSoleno Therapeutics Inc	62,90 € (38,06%)	80
A4YACCENTRO Real Estate AG	0,25 € (28,21%)	33,72k
WS90Provaris Energy Ltd	0,0094 € (27,03%)	20k
MWJNaked Wines Plc	0,928 € (24,23%)	53,44k
YBBCarnavale Resources Ltd	0,0015 € (-50,00%)	6,67k
36GGBM Resources Limited	0,003 € (-33,33%)	29,33k
L09Lithium Energi Exploration Inc	0,007 € (-33,33%)	3,33k
E7TAlexium International Group Share	0,0045 € (-25,00%)	6,97k
FMKEcograf Limited	0,209 € (-19,92%)	5,02M
FMKEcograf Limited	0,209 € (-19,92%)	5,02M
D7GNel ASA	0,2179 € (-3,20%)	2,05M
E3BEutelsat Communications	4,856 € (0,54%)	1,76M
POQ88 Energy Limited	0,0009 € (-10,00%)	999k
DMJDynaCERT Inc	0,1245 € (0,40%)	996,14k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Tong Ren Tang Technologies Co (TNG)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

TNG Neueste Nachrichten

INSERTING AND REPLACING: Transgene Reports 2013 Half Year Results

Transgene Reports 2013 Half Year Results

Transgene Announces that its Phase 2 study of Pexa-Vec in Second-line Advanced Liver Cancer did not Meet its Primary Endpoint

Transgene Grants Ascend Biopharmaceuticals a License to TG1042, an Immunotherapy to Treat Basal Cell Carcinoma, a Common Type...

Transgene Announces the Nomination of Two New Board Members

Transgene Announces that Platine Pharma Services, an Affiliate, is to Acquire Immuno-Monitoring Activities of Indicia Biotech...

TNG - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Tong Ren Tang Technologies Co (TNG) Börsenkurse

Tong Ren Tang Technologies Co (TNG)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

TNG Neueste Nachrichten

INSERTING AND REPLACING: Transgene Reports 2013 Half Year Results

Transgene Reports 2013 Half Year Results

Transgene Announces that its Phase 2 study of Pexa-Vec in Second-line Advanced Liver Cancer did not Meet its Primary Endpoint

Transgene Grants Ascend Biopharmaceuticals a License to TG1042, an Immunotherapy to Treat Basal Cell Carcinoma, a Common Type...

Transgene Announces the Nomination of Two New Board Members

Transgene Announces that Platine Pharma Services, an Affiliate, is to Acquire Immuno-Monitoring Activities of Indicia Biotech...

TNG - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen